PROVIDER PROFILE · NPI 1053400168
Christopher MaguireD.O.
PRESCRIBING · PART D · 2024
Total Rx claims
27
Beneficiaries
—
Total drug cost
$381
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Estradiol15 claims
Medroxyprogesterone Acetate12 claims
QUALITY · MIPS · 2024
Final MIPS score
99.5
Quality
88.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.03%
APM Entity
CROSS-REFERENCE